Archives
-
Geneticin, G-418 Sulfate: Selection and Antiviral Use Guide
2026-05-22
Geneticin, G-418 Sulfate is widely used for selection of eukaryotic cells expressing the neomycin resistance gene and for inhibiting viral cytopathic effects, notably against Dengue virus serotype 2. This compound is not suitable for applications where non-resistant cell viability or ethanol/DMSO solubility is required, and its use should be confined to workflows involving robust genetic selection or antiviral assays.
-
PKH26 Red Fluorescent Cell Linker Kit: Technical Workflow Gu
2026-05-22
The PKH26 Red Fluorescent Cell Linker Kit provides a robust solution for stable, minimally toxic labeling of cell membrane lipid regions, enabling reliable cell tracing and proliferation detection in vitro and in vivo. It is not suitable for intracellular or non-membrane labeling applications, and users should adhere closely to membrane-specific workflows for reproducible results.
-
5-HT3 Antiemetics Inhibit Renal OCT2/MATE1: Mechanisms & Imp
2026-05-21
George et al. systematically evaluated how five 5-HT3 antagonist antiemetic drugs inhibit renal organic cation transporters OCT2 and MATE1. Their findings clarify the molecular basis for potential drug-drug interactions affecting renal secretion of cationic drugs, underscoring the importance of transporter-mediated mechanisms in clinical pharmacology.
-
Firefly Luciferase mRNA (ARCA, 5-moUTP): Optimizing Reporter
2026-05-21
Firefly Luciferase mRNA (ARCA, 5-moUTP) stands at the forefront of bioluminescent reporter technologies, offering improved translation, stability, and immune evasion for gene expression, cell viability, and in vivo imaging assays. Explore real-world workflows, advanced applications, and expert troubleshooting strategies leveraging APExBIO's rigorously engineered reagent.
-
Innovating RNA Synthesis: Precision with HyperScribe SP6 Kit
2026-05-20
Discover how the HyperScribe SP6 High Yield RNA Synthesis Kit empowers next-generation RNA research with unmatched specificity and yield. This article uniquely examines the intersection of molecular immunology and assay design, offering insights beyond standard workflows.
-
S-Adenosylmethionine (SAM): Mechanisms and CNS Research Evid
2026-05-20
S-adenosylmethionine (SAM, ademetionine) is a universally conserved methyl donor with key roles in DNA, RNA, and protein methylation. SAM is foundational for methylation reactions in proteins and DNA, with clinical and experimental applications in neuropsychiatric and hepatic disorders. High-purity SAM solutions such as APExBIO’s B3513 product enable accurate methylation and CNS research.
-
ABT-888 (Veliparib): Potent PARP Inhibitor for Cancer Resear
2026-05-19
ABT-888 (Veliparib) is a highly selective PARP1/2 inhibitor that enhances DNA damage in tumor cells. It is widely used to sensitize microsatellite instability (MSI) tumor models to chemotherapy and radiation. The compound's robust in vitro and in vivo efficacy underpins its value in translational cancer research.
-
Bile Acid Metabolism Subtypes Reveal Prognostic Markers in C
2026-05-19
Feng et al. introduced a molecular subtyping of colorectal cancer (CRC) based on bile acid metabolism, identifying CLCA1, UGT2A3, and ZG16 as key genes linked to immune dysfunction and poor prognosis. Their integrative approach refines CRC patient stratification and highlights metabolic-immune crosstalk as a driver of tumor behavior.
-
TCAIM Regulates Mitochondrial Metabolism via OGDH Protein Co
2026-05-18
Wang et al. identify TCAIM as a mitochondrial DNAJC co-chaperone that binds and reduces a-ketoglutarate dehydrogenase (OGDH) protein levels, uncovering a post-translational mechanism that modulates mitochondrial metabolism. This work establishes a new link between mitochondrial proteostasis and core metabolic regulation, with implications for metabolic disease research.
-
Restoring PTEN with mRNA: Strategic Advances in Cancer Thera
2026-05-18
This article explores the translational impact of restoring PTEN tumor suppressor function via advanced mRNA technologies, examining mechanistic underpinnings, experimental validation, and clinical potential. By integrating recent findings on transdermal lipid nanoparticle delivery and spotlighting APExBIO's EZ Cap™ Human PTEN mRNA, it offers strategic guidance for researchers seeking to bridge fundamental insights with next-generation therapeutic innovation.
-
Branched Endosomal Disruptor Lipids Enhance mRNA & RNP Deliv
2026-05-17
Padilla et al. introduce branched endosomal disruptor (BEND) lipids that significantly improve the endosomal escape of mRNA and CRISPR-Cas9 ribonucleoprotein complexes for hepatic gene editing and T cell engineering. This innovation addresses persistent delivery bottlenecks in non-viral nucleic acid therapeutics and informs the development of more efficient lipid nanoparticle platforms.
-
Pterostilbene Delays Dermal Fibroblast Senescence via Mitoch
2026-05-16
Zhou et al. (2025) demonstrate that pterostilbene delays senescence in human dermal fibroblasts by enhancing mitochondrial quality, particularly through the promotion of mitophagy. This mechanistic insight advances the understanding of dermal aging and suggests new strategies for anti-aging interventions in skin.
-
Transdermal Delivery of PTEN mRNA via HA-LNPs for Cancer Imm
2026-05-15
This study introduces hyaluronate-conjugated lipid nanoparticles (HA-LNPs) as a PEG-free, CD44-targeted platform for transdermal delivery of PTEN mRNA in melanoma models. The approach restores tumor suppressor function, enhances immune activation, and offers a promising, biocompatible alternative for localized mRNA-based cancer immunotherapy.
-
Structure-Based Screening Reveals NSP15 Inhibitors for SARS-
2026-05-15
This article reviews the structure-based virtual screening study that identified thymopentin and oleuropein as potent inhibitors of SARS-CoV-2 NSP15, a viral endoribonuclease implicated in immune evasion. The findings provide a rational foundation for targeting NSP15 in antiviral research and highlight the methodological rigor of integrating docking with molecular dynamics simulations.
-
(+)-Bicuculline: Technical Guidance for Neuroscience Assays
2026-05-14
(+)-Bicuculline is a GABAA receptor antagonist used to dissect inhibitory neurotransmission and synaptic NMDA receptor signaling modulation in neuroscience research. It should be employed only in controlled laboratory settings with rigorous attention to solubility and storage. This compound is not intended for diagnostic or medical applications.